Key result
Two cases of COVID-19 associated acute pericarditis showed favorable clinical and echocardiographic evolution after treatment with colchicine.
Why the study?
Cardiac involvement in SARS-Coronavirus-2 infection has been mainly reported as myocarditis, with limited data on acute pericarditis cases.
Case Report (n=2)
Acute pericarditis is a rare but possible cardiovascular complication of COVID-19 that can be successfully managed with colchicine.
Answers are grounded in this paper and cite their sources.
May support colchicine for COVID-19 pericarditis; leaves open need for randomized confirmation.
RÉSUMÉLes atteintes cardiaques ont été décrites dans l’infection à SARS-Coronavirus-2 (Covid-19). Ces dernières sont essentiellement rapportées sous la forme de myocardites [2]. Nous rapportons deux cas de péricardite aigue à Covid-19 dont l’évolution a été favorable. ABSTRACTHeart damage has been described in SARS-Coronavirus-2 infection. Myocarditis has been the mainly reported form [2]. We report two cases of acute pericarditis with Covid-19 whose course was favorable.
No takes yet. Share an insight, caveat, or question.
Amalia et al. (2022) conducted a case report in Acute pericarditis with COVID-19 (n=2). Colchicine was evaluated on Clinical and echocardiographic resolution. Two cases of COVID-19 associated acute pericarditis showed favorable clinical and echocardiographic evolution after treatment with colchicine.
Synapse has enriched 10 related papers. Consider them for comparative context: